Related Experiment Videos
[Apolipoprotein A I-C III-A IV deficiency]
1Department of Internal Medicine, Omiya Red Cross Hospital.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1994
Summary
Familial deficiencies in apolipoprotein A-I, C-III, and A-IV genes are linked to low HDL cholesterol and early heart disease. Genetic analysis reveals deletions or inversions in these linked genes, impacting lipoprotein metabolism.
Area of Science:
- Genetics
- Molecular Biology
- Cardiovascular Science
Context:
- The apolipoprotein A-I, C-III, and A-IV genes are tandemly organized on human chromosome 11.
- Familial deficiencies in these apolipoproteins are associated with significant health risks.
Purpose:
- To investigate the genetic basis of familial apolipoprotein A-I, C-III, A-IV deficiency.
- To understand the relationship between genetic variations in the apo A-I, C-III, A-IV gene cluster and lipoprotein metabolism.
Summary:
- Familial apolipoprotein A-I, C-III, A-IV deficiency, characterized by extremely low HDL-cholesterol and premature coronary atherosclerosis, results from genetic defects.
- Analysis of affected individuals revealed complete gene deletions or DNA inversions within the apo A-I, C-III, A-IV gene cluster.
- Restriction Fragment Length Polymorphism (RFLP) studies indicate a strong association between specific gene lesions and decreased HDL, hypertriglyceridemia, and coronary atherosclerosis.
Impact:
- Elucidating the precise nucleotide sequence variations is crucial for understanding the link between the apo A-I, C-III, A-IV gene cluster, lipoprotein metabolism, and coronary atherosclerosis.
- This research provides insights into the genetic underpinnings of dyslipidemia and cardiovascular disease.
- Further studies can inform diagnostic and therapeutic strategies for related genetic disorders.